Trindade, A. J., Thaniyavarn, T., Townsend, K., Klasek, R., Tsveybel, K. P., Kennedy, J. C., . . . El-Chemaly, S. (2020). Alemtuzumab as a Therapy for Chronic Lung Allograft Dysfunction in Lung Transplant Recipients With Short Telomeres. Front Immunol.
Stile di citazione ChicagoTrindade, Anil J., Tany Thaniyavarn, Keri Townsend, Robin Klasek, Karen P. Tsveybel, John C. Kennedy, Hilary J. Goldberg, e Souheil El-Chemaly. "Alemtuzumab As a Therapy for Chronic Lung Allograft Dysfunction in Lung Transplant Recipients With Short Telomeres." Front Immunol 2020.
Citazione MLATrindade, Anil J., et al. "Alemtuzumab As a Therapy for Chronic Lung Allograft Dysfunction in Lung Transplant Recipients With Short Telomeres." Front Immunol 2020.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.